Daily doses may be divided into multiple administrations if preferred (e.g., 125 mcg twice a day) to support tolerability or administration preferences
This level of personalized care ensures that every patient stays on track, motivated, and well-informed throughout their journey
Preliminary clinical data and lab work suggest advantages for fertility, uterine recovery, and ovarian support, though large trials are still sparse
The abdomen is a common site for subcutaneous medications in general, but that does not mean GHK-Cu is approved or appropriate for injection
Source: PMID: 40012567 and glymphatic system research Credit: Sleep medicine and neuroscience research For educational purposes only
Sammen finner vi lsningen som passer deg best